Page last updated: 2024-11-06

19-nortestosterone 17-hemisuccinate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

19-nortestosterone 17-hemisuccinate, also known as nandrolone hemisuccinate, is a synthetic anabolic-androgenic steroid (AAS) that is a derivative of testosterone. It is primarily used as a medication to treat conditions such as anemia and osteoporosis. The drug is typically administered via injection. It is often used in veterinary medicine for treating conditions related to growth, development, and reproductive health. 19-nortestosterone 17-hemisuccinate, like other AAS, can be used to improve athletic performance and build muscle mass. Due to its potential for abuse and side effects, its use in sports is banned.'

19-nortestosterone 17-hemisuccinate: increases solubility of nandrolone [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID94333
SCHEMBL ID17419472
MeSH IDM0186435

Synonyms (18)

Synonym
19-nortestosterone 17-hemisuccinate
6785-62-2
4-[[(8r,9s,10r,13s,14s,17s)-13-methyl-3-oxo-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-17-yl]oxy]-4-oxobutanoic acid
7ikf7ww60t ,
einecs 229-849-7
unii-7ikf7ww60t
17beta-hydroxyestr-4-en-3-one 17-(3-carboxypropionate)
nandrolone succinate
nandrolone hemisuccinate
succinic acid 19-nortestosterone monoester
nandrolone hydrogen succinate
estr-4-en-3-one, 17.beta.-hydroxy-, hydrogen succinate
stenoplex
19-nortestosterone succinate
succinic acid, monoester with 17.beta.-hydroxyestr-4-en-3-one
SCHEMBL17419472
DTXSID70987197
Q27268353
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's3 (60.00)18.2507
2000's2 (40.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.50

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.50 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.29 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.50)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]